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Summary
 
T cell activation and clonal expansion is the result of the coordinated functions of the receptors
for antigen and interleukin (IL)-2. The protein tyrosine kinase p56
 
lck 
 
is critical for the genera-
tion of signals emanating from the T cell antigen receptor (TCR) and has also been demon-
strated to play a role in IL-2 receptor signaling. We demonstrate that an IL-2–dependent, anti-
gen-specific CD4
 
1
 
 T cell clone is not responsive to anti-TCR induced growth when
propagated in IL-2, but remains responsive to both antigen and CD3
 
e
 
-specific monoclonal an-
tibody. Survival of this IL-2–dependent clone in the absence of IL-2 was supported by overex-
pression of exogenous Bcl-xL. Culture of this clonal variant in the absence of IL-2 rendered it
susceptible to anti-TCR–induced signaling, and correlated with the presence of kinase-active
Lck associated with the plasma membrane. The same phenotype is observed in primary, resting
CD4
 
1
 
 
 
T cells. Furthermore, the presence of kinase active Lck associated with the plasma mem-
brane correlates with the presence of ZAP 70–pp21
 
z
 
 complexes in both primary T cells and T
cell clones in circumstances of responsive anti-TCR signaling. The results presented demon-
strate that IL-2 signal transduction results in the functional uncoupling of the TCR complex
through altering the subcellular distribution of kinase-active Lck.
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T
 
cell activation and subsequent growth is dependent
upon the coordinated expression and function of the
 
a/b
 
-TCR and the IL-2 receptor (1–6). Expression of the
high affinity receptor for IL-2, as well as the de novo tran-
scription and translation of IL-2, is induced upon T cell an-
tigen recognition (7–10). The control of T cell growth in
these circumstances is regulated through the autocrine pro-
duction and use of IL-2, which are interrelated processes in
that the loss of high levels of membrane IL-2R
 
a
 
 chain ex-
pression and the production of IL-2 are coordinated (11–15).
IL-2 has also been shown to predispose T cells to apoptosis
upon subsequent interaction with antigen (16). Further-
more, the exposure of T cell clones to exogenous IL-2 can
result in their inability to respond to antigen (17). Thus,
IL-2 is essential in supporting T cell clonal expansion, and
is also involved in a feedback regulatory mechanism limit-
ing cellular expansion and/or function.
The JAK/STAT pathway is central in the transduction
of IL-2R signaling (18–23). However, a role for src family
tyrosine kinases has also been demonstrated. Specifically,
stimulation of human T cell clones with exogenous IL-2
results in the activation of p56
 
lck
 
, which is independent of
its association with either CD4 or CD8 (24, 25). Lck has
also been shown to associate with the 
 
b
 
 chain of the IL-2
receptor (25), which is critical for IL-2–mediated Lck acti-
vation (26).
We have developed a T cell clonal system that provides
further insight into the mechanisms underlying the coordi-
nated function of the TCR and the IL-2R. The antigen re-
ceptor signaling phenotypes of CD4
 
1
 
 and CD4
 
2
 
 variants
of an IL-2–dependent, ovalbumin-specific T cell clone
have been described previously (27). Specifically, although
both variants respond to antigen and mAbs specific for
CD3
 
e
 
, only the CD4
 
2
 
 variant responds to mAbs specific
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for TCRC
 
b
 
 or V
 
b
 
. Expression of exogenous wild-type
CD4, but not mutated CD4 unable to bind Lck, in CD4
 
2
 
variants restored their TCR–CD3 signaling phenotype to
that of cells expressing endogenous CD4. Thus, the refrac-
toriness of clones expressing wild-type CD4 to TCR-spe-
cific mAbs correlates with the sequestration of cellular Lck
by CD4 (27).
The role of Lck in T cell antigen receptor signaling is
well established. Biochemical (28–38), and genetic (39–46)
analyses demonstrate that its presence and activity are re-
quired for the most proximal signaling events initiating
through the TCR. Thus, it is plausible that the sequestra-
tion of Lck by CD4 in the above described clonal system
disables the transmission of the most proximal signals ema-
nating from the TCR.
However, the above observations in the CD4
 
1
 
 T cell
clones do not correspond well with TCR–CD3 signaling
phenotypes observed in primary CD4
 
1
 
 T cells. Specifically,
the latter do respond to mAb specific to TCRC
 
b
 
, albeit
less robustly than they respond to mAb specific for CD3
 
e
 
(47–49). An obvious difference within this comparison is
the state of activation of the cells involved. Primary CD4
 
1
 
lymph node T cells are in the majority resting, with 
 
.
 
95%
in the G
 
0 
 
phase of the cell cycle. In contrast, the CD4
 
1
 
 T
cell clones are maintained in exogenous IL-2 before assay,
and are in the majority, cycling. Although a significant pro-
portion of these cycling cells contain a diploid content of
DNA, these cells cannot be equated with noncycling cells
in G
 
0
 
. Since IL-2 has been shown to affect the physiology
of Lck (24, 25), coupled with the obligate role of Lck in
TCR signaling, the observed TCR signaling phenotype in
CD4
 
1
 
 
 
IL-2–dependent clones may reflect an IL-2–medi-
ated physical and/or functional redistribution of cellular Lck.
This study was undertaken to characterize the molecular
basis of IL-2–mediated perturbation of TCR signaling. We
demonstrate that exogenous IL-2 disables anti-TCR–, but
not anti-CD3–induced T cell growth, and that the permis-
sive anti-TCR signaling phenotype correlates with the
presence of kinase-active Lck associated with the plasma
membrane. Primary CD4
 
1
 
 T cells, which are also respon-
sive to anti-TCR–induced growth, are also shown to have
kinase-active Lck at the plasma membrane. Furthermore,
permissive anti-TCR signaling is shown to correlate with
the presence of ZAP-70–pp21
 
z
 
 complexes in both primary
T cells and clones deprived of IL-2.
 
Materials and Methods
 
Mice.
 
C57BL/6 male mice, 6–8 wk old, were purchased
from Charles River Canada, Inc. (Laval, Quebec, Canada) or
The Jackson Laboratory (Bar Harbor, ME), and maintained in a
pathogen-free animal facility at the Ontario Cancer Institute
(Toronto, Ontario, Canada).
 
Antibodies.
 
Hamster mAbs H57.597 (anti-TCRC
 
b
 
) and
145.2C11 (anti-CD3
 
e
 
), and rat mAbs KT410.1 (anti-V
 
b
 
4) and
H.129 (anti-CD4) were purified as previously described (27).
Both rabbit polyclonal anti-Lck (50) and rabbit polyclonal anti–
ZAP-70 (51) were prepared by Dr. A. Veillette. The phosphoty-
rosine-specific mouse mAb 4G10 (52) was supplied by Dr. B.
Druker (Oregon Health Sciences University, Portland, OR), and
the 
 
z
 
 chain–specific mouse mAb G3 (53) was supplied by Dr.
H.-S. Teh (UBC, Vancouver, British Columbia, Canada). Puri-
fied polyclonal rabbit anti–Bcl-x (54) was prepared by Dr. L. Boise.
4G10 immunoblots were developed with horseradish peroxidase
(HRP)
 
1
 
-conjugated polyclonal goat anti–mouse IgG (Sigma
Chemical Co., St. Louis, MO), in 1% gelatin (Bio-Rad, Hercules,
CA). Immunoblots probed with rabbit anti-lck, rabbit anti–Zap-
70, or rabbit anti–Bcl-x were developed with HRP-conjugated
Protein A (ICN Biomedicals, Inc., Irvine, CA) in 5% nonfat dry
milk. Biotinylated CD4 was revealed with HRP-conjugated
streptavidin (Amersham Pharmacia Biotech, Piscataway, NJ) in
0.5% nonfat dry milk. Polyclonal rabbit anti–rat Ig was purchased
from Bio/Can Scientific (Mississauga, Ontario, Canada).
 
Cell Preparation and Culture.
 
Clones were maintained at 0.5–
1.0 
 
3 
 
10
 
6
 
 cells/ml in serum-free IMDM supplemented with 10
U/ml (1%) rIL-2 as previously described (27). Experiments in-
volving rescue of responsive anti-TCR signaling in the presence
of low concentrations of IL-2 required that CD4
 
1
 
 clones be anti-
gen pulsed, which increased their sensitivity to IL-2. Specifically,
clone 2.5 was cocultured with irradiated C57BL/6 spleen cells
and 1–10 
 
m
 
g/ml of the ovalbumin-derived peptide
 
143–157
 
 for 48 h
in the absence of rIL-2. Cultures were harvested and irradiated
filler cells were removed by centrifugation through Lympholyte-M
(Cedarlane Labs. Ltd., Hornby, Ontario, Canada). Viable T cell
blasts were washed and seeded 
 
$
 
0.5 
 
3 
 
10
 
6
 
 cells/ml in serum-free
IMDM supplemented with 10, 3, or 1 U/ml rIL-2. Clones were
incubated at 37
 
8
 
C in 5% CO
 
2 
 
for 4 d, after which cells were
harvested and proliferation assays were set up as previously de-
scribed (27).
For overexpression of Bcl-xL in clone 2.5, 10
 
7
 
 cells in 0.5 ml
IMDM received either 15 
 
m
 
g of pSFFV-Neo empty vector or
pSFFV–bcl-xL (55, 56). A 0.8-kb EcoRI fragment of Bcl-xL
cDNA containing one asymmetric HindIII site was cloned into
the EcoRI site of pSFFV-Neo. The plasmid was not deliberately
linearized before electroporation. Cells were incubated with plas-
mid for 10 min at room temperature and were transferred to 0.4-
cm electroporation cuvettes (Bio-Rad) and electroporated (Bio-
Rad Gene Pulser) at 260 V, 960 
 
m
 
F. Cells were then incubated
for an additional 10 min, harvested into IMDM containing 2.5%
heat-inactivated FCS, and washed once. Cells were resuspended
and cultured for 48 h in IMDM supplemented with 1% rIL-2.
G418 (0.5 mg/ml) was added at 48 h, and a drug-resistant popu-
lation was selected over 2 wk and subsequently cloned by micro-
manipulation. Clones were then assessed for the expression of
Bcl-xL by immunoblotting. Clone 2.5.2 was selected for all sub-
sequent studies.
To “rest” clone 2.5.2, cells were expanded in IMDM contain-
ing 0.3% rIL-2 to high density. Cells were harvested, washed
twice, and seeded at 2 
 
3 
 
10
 
6
 
 cells/well in multiple 24-well cul-
ture plates (Costar Corp., Cambridge, MA) along with 2 
 
3 
 
10
 
6
 
freshly prepared, irradiated, syngeneic C57BL/6 spleen cells. Cul-
tures were incubated in IMDM with no rIL-2 at 37
 
8
 
C in 5%
CO
 
2
 
 for 24 h. Cells were harvested and dead cells and fillers were
removed by centrifugation over Lympholyte-M. Cell cycle status
of these “rested” populations were assessed for each experiment as
described below.
 
1
 
Abbreviations
 
 
 
used in this paper:
 
 HMF, heavy membrane fraction; HRP,
horseradish peroxidase. 
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Primary CD4
 
1
 
 lymph node T cells were prepared as previ-
ously described (48). In brief, axillary nodes, brachial nodes, in-
guinal nodes, and superficial cervical nodes were isolated from
6–8-wk-old C57BL/6 mice. Cell suspensions were washed,
counted, incubated on ice with rat anti-CD8, and passed over
mouse “T cell columns” (BioTex Labs., Edmonton, Alberta, Can-
ada) pretreated with goat anti–rat IgG to remove CD8
 
1
 
 T cells
and goat anti–mouse IgG to remove B cells. Effluent cells from
these columns were typically 
 
.
 
98% CD4
 
1
 
.
Cell cycle status of lymphocyte populations was assessed using
propidium iodide. In brief, 2 
 
3
 
 10
 
5 
 
cells were pelleted, aspirated
dry, and resuspended by dropwise addition of ice-cold Vindelov’s
low salt solution containing 3.4 mM Tris, pH 8.0, 75 
 
m
 
M pro-
pidium iodide, 0.1% vol/vol NP-40, 10 mM NaCl, and 700
U/liter ribonuclease (Boehringer Mannheim, Indianapolis, IN)
(59). Suspensions were incubated on ice for 10 min and revor-
texed before analysis on a FACScan
 
Ò
 
 (Becton Dickinson, San
Jose, CA). Data were acquired at a flow rate of 20 events/s using
the FL2 channel and doublet discrimination. Analysis was carried
out using Lysis II software (Becton Dickinson) on FL2 (A).
 
Cell Fractionation.
 
Preparation of membranes and cytosol used
procedures previously described in detail (57). In brief, cells were
pelleted and resuspended in ice-cold calcium- and magnesium-
free PBS in chilled borosilicate tubes (Fisher Scientific Co., Pitts-
burgh, PA). After two more washes in ice-cold PBS, the cells
were resuspended to a final volume not exceeding 0.5 ml at 2 
 
3
 
10
 
7
 
 cells/ml in ice-cold hypotonic extraction buffer containing
25 mM Hepes, pH 7.0, 1 mM MgCl
 
2
 
, 1 mM EGTA, and 100
 
m
 
g/ml each of leupeptin and aprotinin. Cells were incubated on
ice for 40 min, then subjected to 20 “shears” per tube (avoiding
foaming) using a 30-gauge needle on a 1-ml syringe barrel.
Sheared material was examined microscopically to verify that no
intact cells remained and nuclear material was removed by cen-
trifugation. The volume of the final supernatant was measured,
transferred to Eppendorf tubes, and centrifuged at 12,000 
 
g
 
 for 10
min. The pellet from this spin contains the heavy membrane frac-
tion (HMF) and the supernatant contains the cytosol. The cytosol
fraction was centrifuged at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C, the superna-
tant of which was resolubilized in 0.1% Triton X-100 for 45 min
with gentle agitation before immunoprecipitation. The HMF was
washed once in 200 
 
m
 
l of ice-cold extraction buffer containing
0.1% delipidated BSA (Boehringer Mannheim), and resuspended
to 4 
 
3
 
 10
 
7
 
 cell equivalents/ml in ice-cold extraction buffer con-
taining 0.1% Triton X-100. This suspension was solubilized with
gentle agitation and then centrifuged at 12,000 rpm for 10 s to re-
move detergent-insoluble material. The supernatant of this spin
contains the detergent-soluble HMF.
Biotinylation of cell surface proteins was achieved as follows.
Cells were harvested and washed in ice-cold calcium- and mag-
nesium-free PBS and resuspended to 10
 
7
 
 cells/ml in borate buffer
containing 10 mM anhydrous sodium borate and 150 mM NaCl,
pH 8.8. Long chain biotin stock (Pierce Chemical Co., Rock-
ville, IN) was dissolved in DMSO to a concentration of 10 mg/ml,
and the appropriate volume was added to the cell suspension to
achieve a final concentration of 50 
 
m
 
g/ml. Cells were incubated
with biotin for 10 min at room temperature with frequent, gentle
vortexing. The reaction was stopped by the addition of 10 
 
m
 
l/ml
of 1 M NH
 
4
 
Cl. Cells were washed three times in room tempera-
ture PBS containing 10 mM Tris and 1mM EDTA and was ex-
amined microscopically for viability, which was typically 
 
.
 
95%.
An aliquot of cells was stained with PE-conjugated streptavidin
(Southern Biotechnology Associates, Huntington, AL) to deter-
mine efficiency of cell biotinylation.
 
Immunoprecipitation and Immunoblotting.
 
Precipitation of Lck,
CD4, and Bcl-xL for immunoblotting was achieved by lysing ei-
ther T cell clones or primary CD4
 
1
 
 lymph node T cells at 4 
 
3
 
10
 
7
 
 cells/ml in hypotonic TNE lysis buffer (50 mM Tris, pH 8.0,
20 mM EDTA, 100 
 
m
 
M oxidized sodium orthovanadate, 50 mM
sodium fluoride, 20 
 
m
 
g/ml each of leupeptin and aprotinin [Boeh-
ringer Mannheim], 100 
 
m
 
g/ml Pefabloc [Boehringer Mann-
heim], 50 
 
m
 
g/ml 
 
l
 
-1-chloro-3-(4-tosylamido)-7-amino-2-hep-
tanone hydrochloride [TLCK; Boehringer Mannheim], and 1%
NP-40). Cells were lysed in prechilled Eppendorf tubes on ice for
40 min and centrifuged at 4
 
8
 
C at 12,000 
 
g
 
 for 10 min. The super-
natant was transferred to fresh Eppendorf tubes and maintained
on ice until ready for use.
Immunoblotting for Bcl-xL from whole cell lysates was
achieved by adding 12.5 
 
m
 
l of lysate (0.5 
 
3 
 
10
 
6 
 
cell equivalents)
to 12.5 
 
m
 
l of 2
 
3
 
 Laemmli sample buffer plus 2.5 ml b-2-ME;
samples were boiled for 5 min, and proteins were resolved by
12.5% SDS-PAGE for 900 V h and processed as described below.
Antibodies used for quantitative immunoprecipitation were affin-
ity purified and covalently coupled to activated cyanogen bro-
mide Sepharose 4B (Amersham Pharmacia Biotech, Piscataway,
NJ). Quantitative immunoprecipitations from total cell lysates or
membrane/cytosol preparations from CD41 cells was accom-
plished by four consecutive immunoprecipitations from lysate
containing 6 3 106 cell equivalents with Sepharose-coupled anti-
CD4, followed by four consecutive precipitations with Sepharose-
coupled anti-Lck. Precipitates were subsequently washed four
times in ice-cold TNE wash buffer, as described above but with-
out protease inhibitors, and resuspended in 10 ml of wash buffer,
to which 10 ml of 23 Laemmli sample buffer and 2 ml of b-2-ME
was added. Samples were boiled for 5 min, and electrophoresed
on 8% SDS-PAGE for 850 V h. Material was transferred to nitro-
cellulose (Schleicher & Schuell, Keene, NH) at 55 V for 2 h. Nitro-
cellulose was blocked for 2 h in 5% (for Lck and Bcl-xL) or 0.5%
(for CD4) lowfat milk dissolved in wash buffer containing 50
mM NaCl, 10 mM Tris, 2.5 mM EDTA, and 0.1% Tween 20,
pH 7.5. The latter buffer was also used as diluent for developing
antibodies and/or reagents.
CD4 immunoblots were developed by addition of HRP-conju-
gated streptavidin (see above) in wash buffer (as above) containing
0.5% milk, and revealed with Renaissance ECL Reagents (NEN,
Boston, MA). CD4 blots were stripped by washing in buffer con-
taining 10 mM Tris-HCl, pH 2.3, and 150 mM NaCl for 15 min
at room temperature, and then reblocked in 5% milk. These im-
munoblots were then reprobed with polyclonal rabbit anti-Lck in
wash buffer containing 5% milk, developed with HRP-conjugated
Protein A in 5% milk, and revealed with DuPont ECL reagents.
Immunoblots probed with antiphosphotyrosine, anti-z, or
anti–ZAP-70 were performed essentially the same way as above.
ZAP-70 was precipitated, nonquantitatively, from lysate contain-
ing 5 3 106 cell equivalents. Cells were lysed in pH 7.4 isotonic
lysis buffer containing 140 mM NaCl, 10 mM Tris, 0.4 mM so-
dium orthovanadate, 10 mM sodium fluoride, 10 mM anhydrous
sodium pyrophosphate, and 1% Triton X-100. This buffer was
supplemented with protease inhibitors as for TNE buffer (see
above). The corresponding wash buffer contained 0.1% Triton
X-100 and no protease inhibitors. Samples were electrophoresed
on 12.5% SDS-PAGE gels, transferred to nitrocellulose, and
blocked in 5% milk (for anti–ZAP-70) or 3% gelatin (for anti-
phosphotyrosine) at 308C. Immunoblots were developed with
HRP-conjugated Protein A in 5% milk (for anti–ZAP-70) or
polyclonal goat anti-mouse IgG in 1% gelatin (for antiphosphoty-
rosine), and subsequently revealed with DuPont ECL reagents.1578 IL-2–mediated Regulation of Lck Activity
Samples were processed for Lck kinase assays as follows. Im-
munoprecipitations from membrane/cytosol preparations were
done in Triton X-100, which was used throughout the kinase as-
say. Otherwise, the detergent was NP-40. Immunoprecipitates
were washed once in ice-cold TNE wash buffer containing 100
mM sodium orthovanadate, once in the same buffer without so-
dium orthovanadate but containing 1M NaCl, once in ice-cold
TNE wash buffer without sodium orthovanadate or NaCl, and fi-
nally in ice-cold 13 Lck kinase buffer containing 20 mM 3-(N-
morpholino) propane sulfonic acid (MOPS), pH 7.0, 5 mM
MgCl2, and 3 mM MnCl2 supplemented with 0.1% NP-40.
Tubes were placed on ice and each received 10 ml of 23 Lck ki-
nase buffer supplemented with 20 mg/ml each of aprotinin and
leupeptin, 100 mg/ml Pefabloc, 50 mg/ml TLCK, and 0.1% NP-
40. The reaction mixture was supplemented with 1 mg of freshly
acid-denatured enolase (Boehringer Mannheim), cold ATP (Boeh-
ringer Mannheim) to yield a final concentration of 50 mM, and
2.5 ml (25 mCi/reaction final) g-[32P]ATP. The reaction was
allowed to proceed at room temperature for 30 min and was ter-
minated by the addition of 25 ml of 23 Laemmli sample buffer
containing 20% b-2-ME. Samples were boiled for 5 min and
electrophoresed on 8% SDS-PAGE for 800 V h. Gels were de-
stained with multiple changes of a solution containing 50%
ddH2O, 40% methanol, and 10% glacial acetic acid over a 24-h
period, and then dried and exposed.
CD4 aggregation followed by assessment of phosphotyrosyl
content and kinase activity of CD4-associated Lck was achieved
as follows. Clone 2.5.2 propagated in 1.0% rIL-2 was harvested,
washed, and resuspended to 107/ml in RPMI (GIBCO BRL,
Gaithersburg, MD) containing 50 mg/ml of the CD4-specific rat
mAb, H129. After a 30-min incubation on ice, cells were pel-
leted, resuspended to 2 3 107/ml and prewarmed for 3 min at
378C. Polyclonal rabbit anti–rat was added to some tubes to a fi-
nal concentration of 50 mg/ml, and cells were mixed, pelleted,
and immediately (within 5–10 s) lysed. CD4 immunoprecipitates
were collected using Protein G–Sepharose. Proteins in these im-
munoprecipitates were resolved by SDS-PAGE transferred to ni-
trocellulose membranes and immunoblotted with the phosphoty-
rosine-specific mAb 4G10 as described above. These membranes
were then stripped as described above and re-probed with anti-
Lck. Alternatively, CD4 immunoprecipitates were subjected to
immune complex kinase assays in the presence of enolase as an
exogenous substrate after the procedure described above.
Results
IL-2–mediated Inhibition of Anti-TCR–induced Growth in
CD41 and CD42 Clonal Variants. Both the CD41 (2.5)
and CD42 (2.10) variants of the ovalbumin-specific T cell
clone were propagated in varying concentrations of rIL-2
for 1 wk. Viable cells were harvested and their capacity to
respond to anti-Vb4 and antigen was assessed. As illustrated
in Fig. 1, there is an inverse correlation between the
amount of exogenous IL-2 used to propagate the CD41
variant and its capacity to subsequently respond to anti-
Vb4. This IL-2–dependent refractoriness to anti-TCR
stimulation is also observed using an mAb specific for
TCRCb (data not shown). The inability to respond to
anti-TCRVb or anti-TCRCb is not due to the compro-
mised expression of the antigen receptor complex at the
plasma membrane. Direct assessment of the membrane lev-
els of TCR and CD3 by immunofluorescence revealed no
differences in cells grown over the range of IL-2 concen-
trations used in this study (data not shown). The highest
concentration of IL-2 used in this experiment (1% 5 10
U/ml) results in a 20-fold inhibition of the anti-TCR re-
sponse of CD41 variants. However, the antigen responses
of cells cultured in 10 vs. 1 U/ml of IL-2 were within a
factor of two of one another (Fig. 1). Thus, IL-2 is not pre-
disposing cells to die upon subsequent ligation of the
TCR–CD3 complex as previously described (16). Rather,
it is profoundly affecting their capacity to respond to
TCR-specific mAbs.
The involvement of cellular Lck in this signaling pheno-
type is derived from the observation that CD42 clonal vari-
ants are not susceptible to this IL-2–mediated effect. Thus,
whether clone 2.10 was propagated in 0.1 or 1.0% IL-2,
the subsequent response to anti-TCR was comparable.
Shown in Fig. 1 is the anti-Vb4 response of clone 2.10,
which was propagated in 1.0% IL-2. To elucidate the role
of Lck, both membrane and cytosolic fractions of clones
2.5 and 2.10 were prepared and the content and enzymatic
activity of Lck contained within these fractions was assessed
quantitatively. This analysis was performed using cells
propagated in 1% IL-2, circumstances in which the CD41
clone 2.5 does not respond to anti-TCR.
As illustrated in Fig. 2 A, quantitative precipitation of
Lck from membrane and cytosolic fractions of clone 2.5
followed by immunoblotting revealed three pools, two of
which were membrane associated, and the third of which
was cytosolic. Phosphorimaging revealed that z70% of cel-
lular Lck in clone 2.5 is associated with the membrane frac-
tion, and that within this fraction .85% is associated with
CD4. A comparable membrane/cytosol distribution of Lck
is observed in clone 2.10 despite the absence of CD4 (Fig.
2 A). Immune complex kinase assays were performed in
Figure 1. IL-2–mediated inhibition of anti-TCRVb–induced growth.
Clones 2.5 and 2.10 were stimulated with peptide (OVA143–157) at 10 mM
in the presence of irradiated syngeneic splenocytes for 48 h. Activated
cells were harvested and expanded in medium supplemented with the in-
dicated concentrations of rIL-2. After 4 d, cells were harvested from these
cultures and stimulated with the indicated concentrations of anti-Vb4 or
OVA143–157 in the presence of irradiated syngeneic splenocytes (see Mate-
rials and Methods). At 40 h, cultures were pulsed with 1 mCi of [3H]TdR
and harvested 6 h later, and levels of thymidine incorporation were assessed
by liquid scintillation spectroscopy. Counts represent the mean of triplicate
cultures; 1 SE was within 15% of the indicated means for all cultures.1579 Haughn et al.
parallel with Lck protein analyses within each of the iso-
lated pools, from each of the clonal variants. As shown in
Fig. 2 B, the cytosolic pools from both clonal variants con-
tained kinase-active Lck, revealing a robust phosphoryla-
tion of the exogenous substrate, enolase, coupled with a
weak autophosphorylation signal. Neither the CD4-associ-
ated nor the non-CD4-associated pools of membrane Lck
of clone 2.5 exhibited detectable kinase activity (Fig. 2 B).
In marked contrast, membrane-associated Lck derived from
clone 2.10 was kinase active (Fig. 2 B).
Of note is that, based on the enolase signals observed,
the specific activity of cytosolic Lck derived from clone
2.10 appears higher than that of the analogous Lck pool de-
rived from clone 2.5 (Fig. 2 B). Densitometric analysis of
these enolase signals, normalized to the content of Lck
within the respective precipitates, reveals that the signal de-
rived from clone 2.10 is 2.3-fold higher than that derived
from clone 2.5. Thus, the differences in the kinase activities
observed in these clonal variants may not be restricted to
the plasma membrane-associated pools of Lck, exclusively.
The comparison of these clonal variants suffers from what
may be more complicated affects mediated by CD4 on cel-
lular Lck in general. Although the distinct subcellular distri-
bution of Lck kinase activity in the CD41 and CD42 clonal
variants described above could reflect the underlying differ-
ences in their susceptibility to anti-TCR–mediated growth,
a potential caveat relates to the role of CD4 in altering the
function of cellular Lck. A direct comparison of the subcel-
lular distribution and enzymatic activity of Lck in anti-
TCR permissive and nonpermissive CD41 variants is re-
quired to obviate this concern. The low number of cells
rescued after culturing CD41 clone 2.5 in concentrations
of exogenous IL-2 that supported subsequent responses to
anti-TCR (Fig. 1) precluded our analyses. Therefore, we
took advantage of the recent demonstration showing that
forced expression of exogenous Bcl-xL was able to main-
tain the viability of IL-2–dependent T cells after with-
drawal of IL-2 (58).
Overexpression of Bcl-xL Enables IL-2 Withdrawal and Rescue
of Permissive TCR-a/b Signaling. Bcl-xL was cloned into
the expression vector pSFFV-neo (55, 56) and electro-
porated into clone 2.5. G418 resistant cells were propa-
gated and clones were derived from this expanded drug re-
sistant population. The level of Bcl-xL expressed in clone
2.5.2, in comparison to that expressed by clone 2.5, is illus-
trated in Fig. 3 A. Quantitation of this immunoblotting
analysis revealed that the transfected clone 2.5.2 expressed
z2.5-fold more Bcl-xL than the endogenous levels ex-
pressed by clone 2.5.
Clone 2.5.2 was then cultured in the presence of irradi-
ated syngeneic splenocytes in medium containing either 10
U/ml of rIL-2 or no IL-2. Viable cells harvested 24 h after
initiation of these cultures were assessed for cell cycle status
using propidium iodide (59). As shown in Fig. 3 B, of those
cells expressing $2n DNA content, roughly one-third of
the cells derived from IL-2–containing cultures were in the
S and G2/M phases of cycle, compared with 2% of the cells
that were harvested from cultures containing no IL-2. Of note
is that levels of expression of TCRCb, CD3e, and CD4, as
assessed by immunofluorescence analysis of clone 2.5.2,
were unaffected by exposure to IL-2 (data not shown).
The question followed whether clone 2.5.2 cultured in
the absence of exogenous IL-2 was now responsive to anti-
TCR mediated growth. As depicted in Fig. 3 C, this was
indeed the case. Thus, once “rested” for 24 h in the ab-
sence of exogenous IL-2, clone 2.5.2 responded as robustly
to anti-TCR as it did to anti-CD3e (Fig. 3 C). In contrast,
and as for clone 2.5, clone 2.5.2 was unresponsive to anti-
TCR if derived from cultures containing 10 U/ml rIL-2.
However, consistent with the phenomenon of IL-2–medi-
ated functional uncoupling of TCR and CD3 signaling,
these cells responded robustly to anti-CD3e (Fig. 3 C).
Permissive Anti-TCR Signaling Correlates with the Presence
of Membrane-associated, Kinase-active Lck. The availability of
anti-TCR responsive and nonresponsive CD41 clonal vari-
ants enabled a direct comparison of the cellular distribution
and activity of Lck in these two circumstances. Towards
Figure 2. Cellular distribution and activity of Lck in clones 2.5 and
2.10. (A) Membrane (M) and cytosol (C) fractions of clones 2.5 (CD41)
and 2.10 (CD42) were prepared as described in Materials and Methods
(also see legend to Fig. 4). Solubilized membrane fraction from clone 2.5
(6 3 106 cell equivalents) was subjected to four sequential precipitations
with CD4-specific mAb followed by four sequential precipitations with
polyclonal anti-Lck. Solubilized cytosol from clone 2.5 (6 3 106 cell
equivalents) was subjected to four sequential precipitations with poly-
clonal anti-Lck. Solubilized membrane (M) and cytosol (C) fractions from
clone 2.10 (6 3 106 cell equivalents) were each subjected to three se-
quential precipitations with polyclonal anti-Lck. Precipitates were re-
solved by 8% SDS-PAGE, transferred to nitrocellulose, blocked, and sub-
sequently probed with polyclonal anti-Lck, followed by HRP-conjugated
Protein A, and developed using DuPont ECL reagents as described in
Materials and Methods. (B) Solubilized membrane (M) and cytosol (C)
fractions (6 3 106 cell equivalents) from each of clones 2.5 (CD41) and
2.10 (CD42) were prepared as described in Materials and Methods. Solu-
bilized membranes from clone 2.5 (6 3 106 cell equivalents) were sub-
jected to four sequential precipitations with CD4-specific mAb, followed
by four sequential precipitations with polyclonal anti-Lck and solubilized
cytosol (6 3 106 cell equivalents) was subjected to four sequential precipi-
tations with polyclonal anti-Lck. Solubilized membrane and cytosol frac-
tions from clone 2.10 (6 3 106 cell equivalents each) were precipitated as
for cytosol from clone 2.5. The first three precipitates were pooled from
each of the above series, and the fourth precipitation of each series was as-
sayed separately to ensure clearance. Immune complexes were washed
and processed for in vitro Lck kinase activity as described in Materials and
Methods. Shown here is a 24-h exposure.1580 IL-2–mediated Regulation of Lck Activity
this end, CD41 clone 2.5.2 was propagated in 10 U/ml
IL-2, or rested in the absence of exogenous IL-2. Viable
cells were rescued from each of the two culture conditions,
followed by the preparation of membrane and cytosol frac-
tions. To control the cell fractionation technique used, cells
derived from the two conditions were biotinylated and
CD4 was used as a membrane marker. As illustrated in Fig.
4, immunoprecipitation from “membrane” but not “cyto-
solic” fractions with anti-CD4 revealed the appropriate
signal. Sequential precipitation with anti-CD4, from bio-
tinylated membrane fractions of both resting and IL-2–
propagated 2.5.2 was followed by sequential precipitation
with anti-Lck. Precipitates were fractionated by SDS-
PAGE, immunoblotted and developed with enzyme-linked
streptavidin.
As illustrated in Fig. 4, the CD4 signal was cleared by
anti-CD4 and not detectable in subsequent anti-Lck pre-
cipitates. Stripping the immunoblot followed by probing
with anti-Lck revealed that CD4 associated Lck had been
cleared, and that membrane Lck not associated with CD4
was subsequently rescued, quantitatively, with anti-Lck
(Fig. 4). The cytosolic fractions from the two 2.5.2 popula-
tions were sequentially precipitated with anti-CD4, fol-
lowed by anti-Lck, as described above for the membrane
fractions. As shown in Fig. 4, developing the immunoblot
with enzyme-linked streptavidin did not reveal a CD4 sig-
Figure 3. IL-2 dependence of anti–TCR-a/b signaling. (A) Clone 2.5
was electroporated with 15 mg of pSFFV-Neo–Bcl-xL as described in
Materials and Methods, followed by selection in the presence of 0.5 mg/ml
active G418, and G418-resistant cells were subsequently cloned by micro-
manipulation. Illustrated is a comparison of the levels of Bcl-xL in whole
cell lysates (0.5 3 106 cell equivalents) of clone 2.5 (wild-type) and clone
2.5.2 (Bcl-xL). Phosphorimaging revealed that clone 2.5.2 expresses
roughly 2.23 the level of endogenous Bcl-xL present in clone 2.5. (B)
Clone 2.5.2 was propagated in 10 U/ml rIL-2, or rested in the absence of
rIL-2 for 24 h in the presence of irradiated syngeneic splenocytes, as de-
scribed in Materials and Methods. 2 3 105 cells cultured in each of the
two conditions were pelleted and resuspended in ice-cold Vindelov’s so-
lution, incubated for 10 min on ice, and analyzed for cell cycle status flow
cytometrically using a FACScanÒ equipped with doublet discrimination
software. (C) Clone 2.5.2 cultured either in the presence or absence of
rIL-2, as for Fig. 3 B, was harvested and analyzed for its capacity to re-
spond to various stimuli. 5 3 104 cells from either of the two culture con-
ditions were cocultured with 5 3 105 irradiated syngeneic splenocytes in
0.2 ml of serum-free IMDM containing the indicated stimuli: Con A at 1
mg/ml; OVA143–157 at 10 mM; mAb H57 specific for TCRCb at 0.1 mg/ml;
mAb KT4.10 specific for TCRVb4 at 0.1 mg/ml; and mAb 145.2C11
specific for CD3e at 0.1 mg/ml. Cultures were pulsed with 1 mCi of
[3H]TdR at 40 h, harvested 6 h later, and levels of thymidine incorpora-
tion were assessed by liquid scintillation spectroscopy. Counts represent
the mean of triplicate cultures; 1 SE was within 15% of the indicated
means for all cultures.
Figure 4. Fractionation of membranes and cytosol from clone 2.5.2.
Clone 2.5.2 was cultured in the presence or absence of exogenous rIL-2,
harvested, and labeled with “long chain” biotin as described in Materials
and Methods. Membrane and cytosol fractions were then prepared from
each of these two biotinylated populations, as described in Materials and
Methods. Membrane and cytosol fractions prepared from 6 3 106 cell
equivalents were subjected to four sequential precipitations with mAb
specific for CD4, followed by four sequential precipitations with poly-
clonal anti-Lck. Precipitates were resolved by 8% SDS-PAGE, transferred
to nitrocellulose, blocked, and probed with HRP-conjugated streptavidin
to reveal CD4, then stripped, reblocked, and reprobed with polyclonal
anti-Lck, and developed with HRP-conjugated Protein A to reveal the
accompanying Lck signal. Immunoblots were visualized with DuPont
ECL reagents.1581 Haughn et al.
nal, consistent with this fraction being devoid of material
derived from the plasma membrane. However, non-CD4-
associated cytoplasmic Lck was evident (Fig. 4).
This analysis revealed that the cellular distribution of Lck
was not significantly altered in cycling and noncycling pop-
ulations of clone 2.5.2. Thus, as observed in clone 2.5 (Fig.
2), the majority of cellular Lck was associated with the
plasma membrane fraction, and of the two pools compris-
ing this fraction, the majority of Lck was found to be asso-
ciated with CD4.
In marked contrast to the unaltered cellular distribution
of Lck, its enzymatic activity was profoundly affected by
exogenous IL-2 (Fig. 5). Immune complex kinase assays
were performed on membrane and cytosolic fractions of
clone 2.5.2 cultured in the presence and absence of exoge-
nous IL-2 as described above. As illustrated in Fig. 5, the
cytosolic fractions of 2.5.2 cultured in either condition
contained kinase-active Lck. As shown, the enolase signal is
easily detectable, and although the position of autophos-
phorylated Lck is indicated, this signal is barely detectable.
Thus, if kinase-active Lck is required for responsiveness to
anti-TCR stimulation, cytosolic Lck is probably not play-
ing a role.
Assessment of the kinase activities contained within the
two pools of membrane-associated Lck from clone 2.5.2
cultured in the presence and absence of exogenous IL-2 re-
vealed striking differences (Fig. 5). Clone 2.5.2 cultured in
the absence of IL-2 and responsive to anti-TCR–induced
growth (Fig. 3 C) contained membrane-associated Lck that
was kinase active. Both Lck associated with CD4 and that
which was not gave detectable enolase signals, and for the
cytosolic Lck described above, autophosphorylation signals
were virtually undetectable in precipitates from the number
of cell equivalents assayed (Fig. 5). In marked contrast, ki-
nase activity within the analogous pools of membrane-asso-
ciated Lck derived from clone 2.5.2 cultured in 10 U/ml
IL-2 was undectable. Thus, as concluded from the results
obtained with clones 2.5 and 2.10 (Fig. 2), the presence of
membrane-associated, kinase-active Lck correlates with a
permissive anti-TCR signaling phenotype.
CD4-Associated Lck in Clone 2.5.2 Propagated in IL-2 can
be Acutely Activated. There is an obligate requirement for
Lck in the generation of the most proximal signals emanat-
ing from the TCR complex. The observation that clone
2.5.2 propagated in IL-2 cannot respond to TCRVb-spe-
cific mAb raises the question of how the involvement of
Lck is manifest in response to antigen. An obvious differ-
ence between anti-TCR and antigen-induced T cell acti-
vation is the latter’s capacity to recruit CD4, and thus the
CD4-associated pool of Lck, to the activation complex.
However, as shown in Fig. 5, the CD4-associated pool of
Lck is kinase inactive in clone 2.5.2 propagated in IL-2.
The question is whether the activity of this pool may be al-
tered during the T cell response to antigen. Although it has
not been reported that antigen-mediated coaggregation of
CD4 and TCR–CD3 results in the activation of CD4-asso-
ciated Lck, it has been demonstrated that mAb-mediated
aggregation of CD4 does (50, 60). Therefore, we deter-
mined whether mAb-mediated aggregation of CD4 re-
sulted in an alteration in the phosphotyrosyl content and
kinase activity of associated Lck derived from clone 2.5.2
propagated in IL-2.
As illustrated in Fig. 6, this was indeed the case. Specifi-
cally, and corresponding with the results shown in Fig. 5,
when CD4 is not ligated, the associated pool of Lck is not
kinase active (Fig. 6, middle), nor does it contain detectable
levels of phosphotyrosine (Fig. 6, top). However, upon
mAb-mediated aggregation of CD4, both the phosphoty-
rosyl content and the kinase activity of the pool of associ-
ated Lck is elevated (Fig. 6). Thus, the IL-2–mediated
downregulation of the activity of the CD4-associated pool
of Lck in clone 2.5.2 propagated in IL-2 is not irreversible.
Furthermore, these results are consistent with the capacity
Figure 5. Kinase active Lck is associated with membranes of quiescent
clone 2.5.2. Membrane and cytosol fractions were prepared from clone
2.5.2 cultured in the presence or absence of rIL-2, as described in Materi-
als and Methods. Membrane fractions derived from 6 3 106 2.5.2 clones
cultured in each of the two conditions were subjected to four sequential
precipitations with mAb specific for CD4, followed by four sequential
precipitations with polyclonal anti-Lck. Cytosolic fractions from 6 3 106
2.5.2 clones cultured in each of the two conditions were subjected to four
sequential precipitations with polyclonal anti-Lck. Immune complex ki-
nase assays were performed on each of the precipitates as described in Ma-
terials and Methods.
Figure 6. CD4-associated Lck
in clone 2.5.2 propagated in IL-2
can be acutely activated. Clone
2.5.2 propagated in 1.0% IL-2
was harvested, washed, and re-
suspended to 107/ml in RPMI
containing 50 mg/ml of the
CD4-specific rat mAb, H129.
After a 30-min incubation on
ice, cells were pelleted, resus-
pended to 2 3 107/ml, and pre-
warmed for 3 min at 378C. Poly-
clonal rabbit anti–rat was added to some tubes to a final concentration of
50 mg/ml, cells were mixed, pelleted immediately (within 5–10 s), and
lysed. CD4 immunoprecipitates were collected using Protein G–Sepharose
as described in Materials and Methods. The top panel shows the phospho-
tyrosyl content of CD4-associated Lck from cells in which CD4 had been
aggregated or not. The middle panel shows the kinase activity associated
with this pool of Lck from cells in which CD4 had been aggregated or
not. The bottom panel shows the levels of Lck associated with CD4 in
these two circumstances.1582 IL-2–mediated Regulation of Lck Activity
of antigen, but not anti-TCR, to recruit and use the CD4-
associated pool of Lck.
Permissive Anti-TCR Signaling Correlates with the Presence
of Kinase-active Membrane Lck and Constitutive ZAP-70–
pp21z Complexes in Primary T Cells and Clones. To deter-
mine whether the observations described above did or did
not reflect the idiosyncratic behavior of a T cell clone, we
assessed the distribution and enzymatic activity of cellular
Lck in primary CD41 T cells. However, although the par-
titioning of membrane and cytosolic fractions was as effi-
cient as that observed with the T cell clones, we were un-
able to detect kinase activity associated with Lck derived
from any of the fractions. Cells were therefore lysed using
standard technique and immune complex kinase assays
were performed with anti-CD4 and anti-Lck precipitates
from total cell lysate.
As illustrated in Fig. 7 A, sequential precipitation from
lysate derived from primary CD41 lymph node T cells
with anti-CD4 followed by anti-Lck revealed that the ma-
jority of cellular Lck is associated with CD4. The remain-
ing Lck would be partitioned between the membrane and
cytosol. Immune complex kinase assays were performed on
both total cellular Lck and on CD4-associated Lck to en-
sure that we were assessing the activity of some membrane-
associated Lck. As shown in Fig. 7 B, both anti-Lck and
anti-CD4 precipitates mediated robust enolase phosphory-
lation. An Lck autophosphorylation signal was not ob-
served in anti-CD4 precipitates, and only marginally in
anti-Lck precipitates (Fig. 7 B). Anti-TCRCb precipitates
derived from the same lysate were kinase negative (Fig. 7
B). These results support the conclusion that membrane
Lck is kinase active in primary, resting CD41 T cells.
One of the roles of Lck in TCR signaling is to mediate
the phosphorylation of the z chain (33, 34, 36, 60), thus
enabling the recruitment and subsequent activation of
ZAP-70 (32, 33, 35–37). Given that kinase-active Lck is
present in resting primary T cells and T cell clones, it was
of interest to determine the phosphorylation status of the z
chain and whether it was associated with ZAP-70. To-
wards this end, three populations of T cells were analyzed:
clone 2.5.2 cultured in the presence of IL-2; clone 2.5.2
cultured in the absence of IL-2; and primary CD41 lymph
node T cells. Anti-ZAP precipitates were isolated from ly-
sates of each of these three populations, resolved on SDS-
PAGE, and immunoblotted with phosphotyrosine-specific
mAb 4G10 (52) with z chain–specific mAb, G3 (53), and
anti–ZAP-70 (51). The top panel in Fig. 7 C depicts the
pp21 signal that coprecipitated with anti–ZAP-70 in each
of the three populations, revealed with phosphotyrosine-
specific mAb. The middle panel of Fig. 7 C illustrates that
the pp21 signals were also revealed with the z chain–spe-
cific mAb. The bottom panel of Fig. 7 C demonstrates that
equivalent amounts of ZAP-70 were present in precipitates
from each of the three populations.
The results presented in Fig. 7 C indicate that the z
chain is at least partially phosphorylated in primary resting
T cells and in clonal populations that exhibit a permissive
anti-TCR signaling phenotype. Notably, pp21z is present
at much reduced levels in clonal populations derived from
cultures containing IL-2, which are nonpermissive to anti-
TCR. Furthermore, this pp21z is constitutively associated
with ZAP-70 in resting primary T cells, as previously dem-
onstrated (34), and in resting T cell clones. Thus, both pri-
mary resting T cells, and resting clones exhibit a basal level
of pp21z, at least some of which is constitutively associated
with ZAP-70. This phenotype correlates with both the
Figure 7. Kinase-active Lck is
associated with the presence of a
ZAP-70–pp21z complex and
permissive anti–TCR-a/b sig-
naling.  (A) CD41 primary
lymph node T cells were purified
as described in Materials and
Methods. Lysate derived from
4  3  106 cell equivalents was sub-
jected to four sequential precipi-
tations with mAb specific for
CD4, followed by three sequen-
tial precipitations with poly-
clonal anti-Lck. Precipitates
were resolved by 8% SDS-
PAGE, transferred to nitrocellu-
lose, blocked, probed with poly-
clonal anti-Lck, followed with
HRP-conjugated Protein A,
and developed using DuPont ECL reagents. (B) CD41 lymph node T cells were purified as described in Materials and Methods. Immune complex kinase
assays were performed as described in Materials and Methods, on precipitates derived from lysate containing 4 3 106 cell equivalents with mAbs specific
for CD4, TCRCb, and polyclonal anti-Lck. (C) The top row shows the pp21 signal associated with anti–ZAP-70 precipitates from lysates (5 3 106 cell
equivalents) derived from primary CD41 lymph node T cells, and clone 2.5.2 cultured in the presence (IL-2) or absence (REST) of rIL-2. Anti–ZAP-70
precipitates were resolved on 12.5% SDS-PAGE, transferred to nitrocellulose, probed with 4G10 mAb specific for phosphotyrosine, developed with goat
anti–mouse HRP-conjugated IgG, and revealed with DuPont ECL reagents. The middle row shows the pp21z signal associated with the anti–ZAP-70
precipitates. The blot shown in the top row was stripped and reprobed with z chain–specific mAb. The bottom row shows the same series of precipita-
tions as in the top row, but immunoblotted with polyclonal anti–ZAP-70, developed with HRP-conjugated Protein A, and revealed with DuPont ECL
reagents.1583 Haughn et al.
presence of kinase-active Lck at the plasma membrane and
responsiveness to anti-TCR–mediated growth.
Discussion
To gain insight into the mechanism through which IL-2
can affect TCR–CD3 function, we have analyzed the sig-
naling capacity of elements of the antigen receptor com-
plex in a CD41, IL-2 dependent clone. We demonstrate
that IL-2, in a dose dependent fashion, inhibits the capacity
of TCR, but not CD3 specific mAbs to induce T cell pro-
liferation. The forced expression of exogenous Bcl-xL en-
abled the withdrawal of exogenous IL-2 from clone 2.5.2,
and the rescue of cells, .98% of which were in G0 phase of
cycle. This resting clonal population is responsive to anti-
TCR. However, responsiveness to anti-TCR is not strictly
a cell cycle dependent phenomenon. Clone 2.5 propagated
in low concentrations of exogenous IL-2 (1 and 3 U/ml),
do contain a significant proportion of cycling cells, ranging
from 5 to 20%, and yet are responsive to anti-TCR. Thus,
IL-2 appears to function in two domains, one in which it
supports T cell growth without disabling anti-TCR signal-
ing, and another in which IL-2 in excess prohibits the in-
duction of the most membrane proximal signaling events
induced by TCRVb- and TCRCb-specific mAbs (27).
Responsiveness to TCR-specific mAbs in clone 2.5.2
and primary CD41 T cells correlates with the presence of
detectable kinase active Lck at the plasma membrane, and
this compartment of Lck is modulated in response to exog-
enous IL-2. Specifically, IL-2–mediated refractoriness to
anti-TCR in clone 2.5.2 correlates with the absence of de-
tectable kinase-active, membrane-associated Lck. In con-
trast, the cytosolic pool of Lck derived from clone 2.5.2
was kinase active whether or not the cells were responsive
to anti-TCR. Thus, kinase-active cytosolic Lck is probably
not involved in anti-TCR–mediated T cell growth. Con-
sistent with this tenet is previous work demonstrating that
forced expression of exogenous constitutively active Lck
results in a hypersensitive TCR signaling phenotype (29)
only when Lck can tether to the inner leaflet of the plasma
membrane (30). These results support the conclusion that
plasma membrane-associated and cytosolic pools of Lck
support distinct cellular functions (61), and the results pre-
sented here demonstrate that IL-2 may induce a redistribu-
tion of activity within these pools.
Our study extends those first describing the capacity of
IL-2 to alter Lck function (24, 25), with some notable dif-
ferences. The latter studies demonstrated an IL-2–mediated
transient activation of cellular Lck. Mitogen-activated T
cells were propagated in IL-2, then starved of IL-2 before
assessing the effects of subsequent IL-2 exposure on Lck ac-
tivity. Neither the kinase activity of Lck in the initial rest-
ing T cell population, nor the subcellular distribution of the
kinase active Lck induced by IL-2, was assessed. In con-
trast, we have observed an IL-2–mediated downregulation
of Lck kinase activity, specifically of that Lck associated
with the plasma membrane. The high basal level of cytoso-
lic Lck kinase activity observed in both resting and cycling
T cell clones may have precluded our detection of an IL-2–
mediated increase in Lck activity in the cytosolic pool.
However, this basal level of Lck kinase activity appears to
be physiological, as it is observed in primary resting T cells.
No differences in the subcellular distribution of Lck pro-
tein could be correlated with IL-2–induced alterations in
the cellular distribution of Lck kinase activity. It is possible
that, once activated by IL-2, Lck is dislodged from the
plasma membrane to the cytosol, and replaced by kinase-
inactive Lck. This Lck would in turn become activated and
redistribute to the cytosol under continuing IL-2–mediated
pressure. Thus, we posit that use of Lck in IL-2 receptor
signaling (26) results in the redistribution of kinase-active
protein, and thus impairs subsequent anti-TCR–mediated
responses.
According to this paradigm, IL-2–mediated inhibition of
anti-TCR–induced growth would be ameliorated in the
absence of membrane CD4 expression. Anti-TCR and an-
tigen-mediated T cell activation would not engage the
CD4-associated pool of Lck in similar fashions. mAb-medi-
ated T cell activation may predominantly engage that pool
of membrane-associated Lck that is not bound to CD4. In
the absence of membrane CD4 expression, the available
pool of membrane-associated Lck required for anti-TCR
signaling would be larger and therefore proportionally less
depleted by IL-2. This would explain the anti-TCR respon-
siveness of clone 2.10, the CD42 clonal variant of clone
2.5. Thus, when cultured in concentrations of IL-2 that in-
hibit anti-TCR–induced growth of the CD41 clone 2.5,
clone 2.10 is still responsive to anti-TCR–induced growth
(Fig. 1 and reference 27). Furthermore, kinase-active Lck
associated with the plasma membrane is observed in clone
2.10 (Fig. 2). The prediction follows that increasing the
concentration of IL-2 used to propagate clone 2.10 should
ultimately result in the inhibition of anti-TCR–induced
growth, and indeed antigen-induced growth. Anti-TCR–
mediated growth of clone 2.10 propagated in 50–100 U/ml
IL-2 is inhibited, as is the antigen response of both clones
2.5 and 2.10 propagated in these conditions (data not
shown). Similar IL-2–mediated inhibition of the antigen
response of CD41 T cell clones have been reported by
other investigators (17). It is possible that these high con-
centrations of exogenous IL-2 have predisposed cells to an-
tigen receptor–induced apoptosis (16).
The observed differences in the sensitivity of anti-TCR
and antigen induced responses to exogenous IL-2 may reflect
the differential involvement of the CD4 associated compart-
ment of membrane Lck in these two modes of activation.
Thus, doses of IL-2 that virtually ablate the anti-TCR
responses of clones 2.5 and 2.5.2 do not impair their re-
sponses to antigen (Figs. 1 and 3). Membrane-associated Lck
is nonetheless kinase inactive in these cells before antigen
stimulation (Figs. 2 and 5). As previously described for clone
2.5, antibody-mediated coaggregation of CD4 with TCR
does result in robust responses, but only if CD4 is associated
with Lck (27). Thus, as with coaggregation of mAbs, antigen-
mediated juxtaposition of CD4–Lck with the TCR–CD3
complex (62) obviates the requirement for preexisting mem-1584 IL-2–mediated Regulation of Lck Activity
brane-associated kinase-active Lck associated with anti-TCR
responsiveness in resting clones and primary T cells.
Consistent with these notions is the demonstration in
this study that mAb-mediated aggregation of CD4 on
clone 2.5.2 propagated in IL-2 results in the induction of
kinase activity within the CD4-associated pool of Lck (Fig.
6). This result supports the conclusion that the capacity of
antigen, but not anti-TCR, to induce the growth of clone
2.5.2 propagated in these conditions reflects the differential
recruitment of the CD4-associated pool of Lck to the anti-
gen receptor complex. Furthermore, the inactivity of “mem-
brane” Lck in clone 2.5.2 propagated in IL-2 correlates
with undetectable levels of phosphotyrosyl content, sug-
gesting that phosphorylation of Y394, demonstrated by
others to predicate Lck activation, is a probable basis for
this IL-2–mediated Lck phenotype. Thus, IL-2–mediated
downregulation of the basal kinase activity of membrane-
associated Lck in clone 2.5.2 is not irreversible, and can
presumably be rescued by antigen-mediated coaggregation
of CD4 with the TCR–CD3 complex.
The functional uncoupling of mAb-mediated TCR and
CD3 signaling observed in this study is not unprecedented.
The first demonstration involved the characterization of
the differential capacity of anti-TCRCb and anti-CD3e to
induce calcium flux in thymocytes and lymph node T cells
(63). Subsequent studies extended this signaling phenotype
to include mature primary T cells (47–49). The central role
of Lck in this uncoupling phenotype is supported by results
obtained using Lck-deficient T cells. Studies using Lck2
variants of the T cell line, Jurkat, demonstrated that signal-
ing mediated by Ti-specific mAb was profoundly reduced
in comparison to that mediated by CD3e-specific mAb
(42). Furthermore, mAb-mediated signaling through the
TCR in primary T cells from Lck-deficient animals is ab-
lated, whereas that through CD3e is only partially affected
(43). The results presented in this study demonstrate that
IL-2, through altering the subcellular distribution of ki-
nase-active Lck, mediates the same uncoupling phenotype.
Taken together, the results support the conclusion that
mAb-mediated signaling through TCR and CD3 has dif-
ferential requirements for Lck.
Although the role of Lck in generating proximal signals
emanating from the TCR has been established, there is a
paucity of information correlating its cellular location with
its delivery of function. A plausible function of the kinase-
active, membrane-associated Lck described in this study is
the maintenance of a basal level of TCR-z phosphoryla-
tion. In vitro observations have demonstrated that the z
chain can be a substrate for Lck (35, 36). In this study we
demonstrate that the presence of kinase-active Lck at the
plasma membrane correlates with the presence of pp21z
and its constitutive association with ZAP-70. This result
supports and extends the recently published observation
that thymocytes isolated from mice containing a targeted
disruption of the Lck locus do not contain pp21z, whereas
those thymocytes from Lck-sufficient animals do (36). The
pp21z observed in this study represents a hypophosphory-
lated form of the molecule. As previously described (64), it
is accompanied by a pp23 form, induced upon aggregation
of the antigen receptor. Furthermore, immune complex ki-
nase assays indicate that the ZAP-70 in pp21z–ZAP 70
complexes is inactive and is activated only upon aggrega-
tion of the antigen receptor complex (34). Thus, resting T
cells are poised to respond through TCR, and the basal
configuration of the antigen receptor complex supporting
this phenotype is mediated at least in part through the pres-
ence of kinase-active, membrane-associated Lck.
Recent results provide a possible mechanism through
which the basal level of Lck kinase activity reported here
could be induced and maintained in primary resting T cells,
and by extension in resting T cell clones cultured in the
presence of syngeneic irradiated splenocytes. The survival
of mature CD41 and CD81 naive T cells is profoundly
compromised in the absence of MHC class II and MHC
class I expression, respectively, in the periphery (65, 66).
Thus, in MHC null mice, the half-life of mature T cells of
either lineage is markedly reduced. These results support
the conclusion that continuous, and probably low affinity,
interaction of TCR with self-MHC molecules in the ab-
sence of nominal peptide is providing critical survival sig-
nals. The basal configuration of the TCR–CD3 complex
described in this study, comprised of pp21z and its com-
plexes with ZAP-70, could reflect the biochemical conse-
quences of these interactions on the activity of Lck.
We thank C. Cantin and Denis Bouchard and the flow cytometry unit at the Ontario Cancer Institute; Mina
Marmor for help in the isolation of primary CD41 lymph node T cells; and Philippe Poussier and Robert
Rottapel for helpful discussion and critical review of the manuscript.
L. Haughn was supported by a fellowship from the Cancer Research Society, Inc. B. Leung was supported
by a Medical Research Council studentship. A. Veillette is the recipient of an MRC Scientist Award. This
work was supported by grants from the Medical Research Council of Canada, the National Cancer Institute,
and the National Institutes of Health.
Address correspondence to Michael Julius, Arthritis and Immune Disorder Research Centre, Suite 700, 620
University Ave., c/o 610 University Ave., Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-6549;
Fax: 416-946-6589; E-mail: michael.julius@utoronto.ca
Received for publication 17 February 1998 and in revised form 30 July 1998.1585 Haughn et al.
References
1. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 recep-
tor system: a current overview. Cell. 73:5–8.
2. Weiss, A., and D.R. Littman. 1994. Signal transduction by
lymphocyte antigen receptors. Cell. 76:263–274.
3. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K.
Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleu-
kin-2 receptor g chain: its role in the multiple cytokine re-
ceptor complexes and T cell development in XSCID. Annu.
Rev. Immunol. 14:179–205.
4. Wange, R.L., and L.E. Samelson. 1996. Complex complexes:
signaling at the TCR. Immunity. 5:197–205.
5. Cantrell, D. 1996. T cell antigen receptor signal transduction
pathways. Annu. Rev. Immunol. 14:259–274.
6. Alberola-Ila, J., S. Takaki, J.D. Kerner, and R.M. Perlmutter.
1997. Differential signaling by lymphocyte antigen receptors.
Annu. Rev. Immunol. 15:125–154.
7. Cantrell, D.A., and K.A. Smith. 1983. Transient expression
of interleukin 2 receptors. J. Exp. Med. 158:1895–1911.
8. Durand, D.B., J.-P. Shaw, M.R. Bush, R.E. Replogle, R.
Belagaje, and G.R. Crabtree. 1988. Characterization of anti-
gen receptor response elements within the interleukin-2 en-
hancer. Mol. Cell. Biol. 8:1715–1724.
9. Serfling, E., R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius,
R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous
and lymphocyte-specific factors are involved in the induction
of the mouse interleukin 2 gene in T lymphocytes. EMBO
(Eur. Mol. Biol. Organ.) J. 8:465–473.
10. Crabtree, G.R., and N.A. Clipstone. 1994. Signal transmis-
sion between the plasma membrane and nucleus of T lym-
phocytes. Annu. Rev. Biochem. 63:1045–1083.
11. Meuer, S.C., R.E. Hussey, D.A. Cantrell, J.C. Hodgdon,
S.F. Schlossman, K.A. Smith, and E.L. Reinherz. 1984. Trig-
gering of the T3-Ti antigen-receptor complex results in
clonal T-cell proliferation through an interleukin 2-depen-
dent autocrine pathway. Proc. Natl. Acad. Sci. USA. 81:1509–
1513.
12. Smith, K.A., and D.A. Cantrell. 1985. Interleukin 2 regulates
its own receptors. Proc. Natl. Acad. Sci. USA. 82:864–868.
13. Depper, J.M., W.J. Leonard, C. Drogula, M. Kronke, T.A.
Waldmann, and W.C. Greene. 1985. Interleukin 2 (IL-2)
augments transcription of the IL-2 receptor gene. Proc. Natl.
Acad. Sci. USA. 82:4230–4234.
14. Gullberg, M., and K.A. Smith. 1986. Regulation of T cell
autocrine growth T41 cells become refractory to interleukin
2. J. Exp. Med. 163:270–284.
15. Cantrell, D.A., M.K.L. Collins, and M.J. Crumpton. 1988.
Autocrine regulation of T lymphocyte proliferation: differen-
tial induction of IL-2 and IL-2 receptor. Immunology. 65:
343–349.
16. Lenardo, M.J. 1991. Interleukin-2 programs mouse abT
lymphocytes for apoptosis. Nature. 353:858–861.
17. Otten, G., D.B. Wilde, M.B. Prystowsky, J.S. Olshan, H.
Rabin, L.E. Henderson, and F.W. Fitch. 1986. Cloned
helper T lymphocytes exposed to interleukin 2 become unre-
sponsive to antigen and concanavalin A but not to calcium
ionophore and phorbol ester. Eur. J. Immunol. 16:217–225.
18. Johnston, J.A., M. Kawamura, R.A. Kirken, Y.-Q. Chen,
T.B. Blake, K. Shibuya, J.R. Ortaldo, D.W. McVicar, and
J.J. O’Shea. 1994. Phosphorylation and activation of the Jak-3
janus kinase in response to interleukin-2. Nature. 370:151–153.
19. Witthuhn, B.A., O. Silvennoinen, O. Miura, K.S. Lai, C.
Cwik, E.T. Liu, and J.N. Ihle. 1994. Involvement of the
Jak-3 janus kinase in signaling by interleukins 2 and 4 in lym-
phoid and myeloid cells. Nature. 370:153–157.
20. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Mi-
nami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B.A. Witthuhn,
J.N. Ihle, and T. Taniguchi. 1994. Functional activation of
Jak 1 and Jak 3 by selective association with IL-2 receptor
subunits. Science. 266:1045–1047.
21. Russell, S.M., J.A. Johnston, M. Noguchi, M. Kawamura,
C.M. Bacon, M. Friedmann, M. Berg, D.W. McVicar, B.A.
Witthuhn, O. Silvennoinen, et al. 1994. Interaction of IL-
2Rb and g chains with Jak 1 and Jak 3: implications for
XSCID and XCID. Science. 266:1042–1045.
22. Ihle, J.N. 1995. Cytokine receptor signaling. Nature. 377:
591–594.
23. Watanabe, S., and K.-I. Arai. 1996. Roles of the JAK-STAT
system in signal transduction via cytokine receptors. Curr.
Opin. Gen. Dev. 6:587–596.
24. Horak, I.D., R.E. Gress, P.J. Lucas, E.M. Horak, T.A. Wald-
mann, and J.B. Bolen. 1991. T-lymphocyte interleukin
2-dependent tyrosine protein kinase signal transduction in-
volves activation of p56lck. Proc. Natl. Acad. Sci. USA. 88:
1996–2000.
25. Hatakeyama, M., T. Kono, N. Kobayashi, A. Kawahara, S.D.
Levin, R.M. Perlmutter, and T. Taniguchi. 1991. Interaction
of the IL-2 receptor with the src-family kinase p56lck: identi-
fication of novel intermolecular association. Science. 252:
1523–1528.
26. Minami, Y., T. Kono, K. Yamada, N. Kobayashi, A. Kawa-
hara, R.M. Perlmutter, and T. Taniguchi. 1993. Association
of p56lck with IL-2 receptor b chain is critical for the IL-2-
induced activation of p56lck. EMBO (Eur. Mol. Biol. Organ.)
J. 12:759–768.
27. Haughn, L., S. Gratton, L. Caron, R.-P. Sekaly, A. Veillette,
and M. Julius. 1992. Association of tyrosine kinase p56lck
with CD4 inhibits the induction of growth through the
abT-cell receptor. Nature. 358:328–331.
28. Marth, J.D., D.B. Lewis, C.B. Wilson, M.E. Gearn, E.G.
Krebs, and R.M. Perlmutter. 1987. Regulation of pp56lck
during T cell activation: functional implications for the src-
like protein tyrosine kinases. EMBO (Eur. Mol. Biol. Organ.)
J. 6:2727–2734.
29. Abraham, N., M.C. Miceli, J.R. Parnes, and A. Veillette.
1991. Enhancement of T-cell responsiveness by the lympho-
cyte-specific tyrosine protein kinase, p56lck. Nature. 350:62–66.
30. Caron, L., N. Abraham, T. Pawson, and A. Veillette. 1992.
Structural requirements for enhancement of T-cell respon-
siveness by the lymphocyte-specific tyrosine protein kinase
p56lck. Mol. Cell. Biol. 12:2720–2729.
31. Karnitz, L., S.L. Sutor, T. Torigoe, J.C. Reed, M.P. Bell,
D.J. McKean, P.J. Leibson, and R.T. Abraham. 1992. Effects
of p56lck deficiency on the growth and cytolytic effector
function of an interleukin-2-dependent cytotoxic T-cell line.
Mol. Cell. Biol. 12:4521–4530.
32. Chan, A.C., M. Iwashima, C.W. Turck, and A. Weiss. 1992.
Zap 70: a 70 kD protein-tyrosine kinase that associates with
the TCRz chain. Cell. 71:649–662.
33. Iwashima, M., B.A. Irving, N.S.C. van Oers, A.C. Chan, and
A. Weiss. 1994. Sequential interactions of the TCR with two
distinct cytoplasmic tyrosine kinases. Science. 263:1136–1139.
34. van Oers, N.S.C., N. Killeen, and A. Weiss. 1994. Zap-70 is
constitutively associated with tyrosine-phosphorylated TCRz
in murine thymocytes and lymph node T cells. Immunity.1586 IL-2–mediated Regulation of Lck Activity
1:675–685.
35. Chan, A.C., M. Dalton, R. Johnson, G.-H. Kong, T. Wang,
R. Thoma, and T. Kurosaki. 1995. Activation of zap-70 ki-
nase activity by phosphorylation of tyrosine 493 is required
for lymphocyte antigen receptor function. EMBO (Eur. Mol.
Biol. Organ.) J. 14:2499–2508.
36. van Oers, N.S.C., N. Killeen, and A. Weiss. 1996. Lck regu-
lates the tyrosine phosphorylation of the T cell receptor sub-
units and Zap-70 in murine thymocytes. J. Exp. Med. 183:
1053–1062.
37. Yamasaki, S., M. Takamatsu, and M. Iwashima. 1996. The
kinase, SH3, and SH2 domains of lck play critical roles in
T-cell activation after zap-70 membrane localization. Mol.
Cell. Biol. 16:7151–7160.
38. Wiest, D.L., J.M. Ashe, R. Abe, J.B. Bolen, and A. Singer.
1996. TCR activation of zap 70 is impaired in CD41CD81
thymocytes as a consequence of intrathymic interactions that
diminish available p56lck. Immunity. 4:495–504.
39. Teh, H.-S., A.M. Garvin, K.A. Forbush, D.A. Carlow, C.B.
Davis, D.R. Littman, and R.M. Perlmutter. 1991. Participa-
tion of CD4 coreceptor molecules in T-cell repertoire selec-
tion. Nature. 349:241–243.
40. van Oers, N.S.C., A.M. Garvin, C.B. Davis, K.A. Forbush,
D.A. Carlow, D.R. Littman, R.M. Perlmutter, and H.-S.
Teh. 1992. Disruption of CD8-dependent negative and posi-
tive selection of thymocytes is correlated with a decreased as-
sociation between CD8 and the protein tyrosine kinase,
p56lck.  Eur. J. Immunol. 22:735–743.
41. Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, A.
Narendran, E. Timms, A. Wakeham, C.J. Paige, K.-U. Hart-
mann, A. Veillette, et al. 1992. Profound block in thymocyte
development in mice lacking p56lck. Nature. 357:161–164.
42. Strauss, D.B., and A. Weiss. 1992. Genetic evidence for the
involvement of the lck tyrosine kinase in signal transduction
through the T cell antigen receptor. Cell. 70:585–593.
43. Poussier, P., and M.H. Julius. 1995. T cell development and
selection in the intestinal epithelium. Semin. Immunol. 7:321–
334.
44. Anderson, S.J., and R.M. Perlmutter. 1995. A signaling path-
way governing early thymocyte maturation. Immunol. Today.
16:99–105.
45. Groves, T., P. Smiley, M.P. Cooke, K. Forbush, R.M. Perl-
mutter, and C.J. Guidos. 1996. Fyn can partially substitute for
lck in T lymphocyte development. Immunity. 5:417–428.
46. van Oers, N.S.C., B. Lowin-Kropf, D. Finlay, K. Connolly,
and A. Weiss. 1996. ab T cell development is abolished in
mice lacking both lck and fyn protein tyrosine kinases. Immu-
nity. 5:429–436.
47. Newell, M.K., L.J. Haughn, C.R. Maroun, and M.H. Julius.
1990. Death of mature T cells by separate ligation of CD4
and the T-cell receptor for antigen. Nature. 347:286–289.
48. Maroun, C.R., and M. Julius. 1994. Distinct roles for CD4
and CD8 as co-receptors in T cell receptor signalling. Eur. J.
Immunol. 24:959–966.
49. Maroun, C.R., and M. Julius. 1994b. Distinct involvement
of CD45 in antigen receptor signalling in CD41 and CD81
primary T cells. Eur. J. Immunol. 24:967–973.
50. Veillette, A., M.A. Bookman, E.M. Horak, and J.B. Bolen.
1988. The CD4 and CD8 T cell surface antigens are associ-
ated with the internal membrane tyrosine-protein kinase
p56lck.  Cell. 55:301–308.
51. Fournel, M., D. Davidson, R. Weil, and A. Veillette. 1996.
Association of tyrosine protein kinase Zap-70 with the pro-
tooncogene p120c-cbl in T lymphocytes. J. Exp. Med. 183:
301–306.
52. Morrison, D.K., D.R. Kaplan, J.A. Escobedo, U.R. Rapp,
T.M. Roberts, and L.T. Williams. 1989. Direct activation of
the serine/threonine kinase activity of Raf-1 through ty-
rosine phosphorylation by the PDGFb-receptor. Cell. 58:
649–657.
53. van Oers, N.S.C., S.-J. Teh, B.A. Irving, J. Tiong, A. Weiss,
and H.-S. Teh. 1994. Production and characterization of
monoclonal antibodies specific for the murine T cell receptor
z chain. J. Immunol. Methods. 170:261–268.
54. Boise, L.H., A.J. Minn, P.J. Noel, C.H. June, M.A. Acca-
vitti, T. Lindsten, C.B. Thompson. 1995. CD28 costimula-
tion can promote T cell survival by enhancing the expression
of Bcl-xL. Immunity. 3:87–98.
55. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T.
Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thomp-
son. 1993. Bcl-x, a bcl-2-related gene that functions as a
dominant regulator of apoptotic cell death. Cell. 74:597–608.
56. Fuhlbrigge, R.C., S.M. Fine, E.R. Unanue, and D.D. Chap-
lin. 1988. Expression of membrane interleukin 1 by fibro-
blasts transfected with murine pro-interleukin 1a cDNA.
Proc. Natl. Acad. Sci. USA. 85:5649–5653.
57. Hockenbery, D.M., Z.N. Oltvai, X.M. Yin, C.L. Milliman,
and S.J. Korsemeyer. 1993. Bcl-2 functions in an anti-oxi-
dant pathway to prevent apoptosis. Cell. 75:241–251.
58. Boise, L.H., C.L. McShan, and C.B. Thompson. 1996. In-
troduction of the cell survival gene bcl-xL improves the via-
bility of CTLL-2 cells without affecting their IL-2 prolifera-
tive response. Implications for the development of bioassays.
J. Immunol. Methods. 191:143–148.
59. Vindelov, L.L. 1977. Flow microfluorometric analysis of nu-
clear DNA in cells from solid tumors and cell suspensions. A
new method for rapid isolation and staining of nuclei. Vir-
chows Arch. B. Cell Pathol. 24:227–242.
60. Veillette, A., M.A. Bookman, E.M. Horak, L.E. Samelson,
and J.B. Bolen. 1989. Signal transduction through the CD4
receptor involves the activation of the internal membrane ty-
rosine-protein kinase p56lck. Nature. 338:257–259.
61. Xu, H., and D.R. Littman. 1993. A kinase-independent
function of lck in potentiating antigen-specific T cell activa-
tion. Cell. 74:633–643.
62. Kupfer, A., S.J. Singer, C.A. Janeway, Jr., and S.L. Swain.
1987. Coclustering of CD4 (L3T4) molecule with the T-cell
receptor is induced by specific direct interaction of helper T
cells and antigen-presenting cells. Proc. Natl. Acad. Sci. USA.
84:5888–5892.
63. Finkel, T.H., P. Marrack, J.W. Kappler, R.T. Kubo, and J.C.
Cambier. 1989. abT cell receptor and CD3 transduce differ-
ent signals in immature T cells. Implications for selection and
tolerance. J. Immunol. 142:3006–3012.
64. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E.
Samelson, and R.N. Germain. 1995. z phosphorylation with-
out zap 70 activation induced by TCR antagonists or partial
agonists. Science. 267:515–518.
65. Tanchot, C., F.A. Lemonnier, B. Perarnau, A.A. Freitas, and
B. Rocha. 1997. Differential requirements for survival and
proliferation of CD8 naive or memory T cells. Science. 276:
2057–2062.
66. Rooke, R., C. Waltzinger, C. Benoist, and D. Mathis. 1997.
Targeted complementation of MHC Class II deficiency by
intrathymic delivery of recombinant adenoviruses. Immunity.
7:123–134.